Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
Add more filters










Publication year range
1.
Turk J Obstet Gynecol ; 21(2): 70-77, 2024 Jun 10.
Article in English | MEDLINE | ID: mdl-38853455

ABSTRACT

Objective: To evaluate the clinical outcomes of laparoscopic and hysteroscopic surgical approaches for treating symptomatic isthmocele and identify their associated factors. Materials and Methods: Forty-six patients with symptomatic isthmocele diagnosed using transvaginal saline infusion sonohysterography were enrolled in this prospective cohort study. Patients underwent either laparoscopic or hysteroscopic isthmoplasty based on their residual myometrial thicknesses and fertility desires and were subsequently followed by clinical and ultrasonographic examinations. Results: Twenty-two patients underwent laparoscopy and 24 underwent hysteroscopic surgery. At baseline, there was no significant difference in the mean age and years since the last cesarean section between the two groups. However, the hysteroscopy group had a higher mean parity and previous cesarean sections (p=0.00, 0.03). The most common symptoms were abnormal uterine bleeding, infertility, and dysmenorrhea. The mean baseline residual myometrial thickness was significantly higher in the laparoscopy group (p=0.00), and only laparoscopic surgery led to a significant increase in residual myometrial thickness in patients (p=0.00). Both procedures significantly reduced abnormal uterine bleeding (p=0.00), but only laparoscopy reduced infertility (p=0.00) and hysteroscopy reduced dysmenorrhea (p=0.03). Hysteroscopy showed better symptom resolution in younger patients (p=0.01), whereas age did not affect laparoscopy outcomes. Conclusion: Both approaches showed similar effectiveness in resolving abnormal uterine bleeding, with laparoscopy excelling in infertility resolution and hysteroscopy excelling in dysmenorrhea resolution.

2.
Int J Biol Macromol ; 269(Pt 1): 132020, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38704061

ABSTRACT

A series of D-ring fused 16-substituted steroidal quinoxalin-2(1H)-one attached to an electron-releasing (ER) or electron-withdrawing (EW) groups via steroidal oxoacetate intermediate were synthesized to investigate their protein aggregation inhibition potential using human lysozyme (HLZ). The influence of the type of substituent at the C-6 positions of the quinoxalin-2(1H)-one ring on the protein aggregation inhibition potential was observed, showing that the EW moiety improved the protein aggregation inhibition potency. Of all the evaluated compounds, NO2-substituted quinoxalin-2(1H)-one derivative 13 was the most active compound and had a maximum protein aggregation inhibition effect. Significant stabilization effects strongly support the binding of the most biologically active steroidal quinoxalin-2(1H)-one with docking studies. The predicted physicochemical and ADME properties lie within a drug-like space which shows no violation of Lipinski's rule of five except compounds 12 and 13. Combined, our results suggest that D-ring fused 16-substituted steroidal quinoxalin-2(1H)-one has the potential to modulate the protein aggregation inhibition effect.


Subject(s)
Molecular Docking Simulation , Muramidase , Protein Aggregates , Quinoxalines , Quinoxalines/chemistry , Quinoxalines/pharmacology , Protein Aggregates/drug effects , Humans , Muramidase/chemistry , Muramidase/metabolism , Steroids/chemistry , Steroids/pharmacology , Protein Folding
3.
Steroids ; 190: 109154, 2023 02.
Article in English | MEDLINE | ID: mdl-36521632

ABSTRACT

Protein misfolding can lead to fibrillar and non-fibrillar deposits which are the signs of countless human diseases. A promising strategy for the prevention of such diseases is the inhibition of protein aggregation, and the most crucial step toward effective prevention is the development of small molecules having the potential for protein-aggregation inhibition. In this search, a series of novel steroidal pyrido[2,3-d]pyrimidines have been synthesized employing steroidal ketone, substituted aldehydes, and 2,6-diaminopyrimidin-4(3H)-one through the microwave-assisted one-pot multicomponent methodology. The aggregation inhibition potential of newly synthesized compounds was evaluated on human lysozyme (HLZ). All the synthesized compounds were found to be efficient in the inhibition of protein aggregation in carefully designed in vitro experiments. Moreover, molecular docking studies also determine the binding interactions between all the synthesized compounds and native HLZ through hydrogen bonding. The structures of synthesized compounds were also elucidated using various spectroscopic techniques.


Subject(s)
Microwaves , Pyrimidines , Humans , Molecular Docking Simulation , Protein Aggregates , Steroids/chemistry , Drug Development
4.
Steroids ; 188: 109113, 2022 12.
Article in English | MEDLINE | ID: mdl-36152868

ABSTRACT

Zinc oxide nanoparticles (ZnO NPs) were synthesized by a green method using Azadirachta indica leaf extract. The structure of the prepared ZnO (NPs) were characterized by FT-IR, XRD, SEM-EDX and TEM analyses. The biosynthesized ZnO (NPs) were then used as a catalyst for the synthesis of steroidal dihydropyrazole derivatives through a one-pot multicomponent reaction involving phenyl acetylene and hydrazine derivatives. The anticancer activity of newly synthesized compounds were evaluated against three cancer cell lines namely HeLa (human cervical carcinoma), Hep3B (human hepatocellular carcinoma) and MCF7 (human breast adenocarcinoma) by MTT assay. The tested compounds were found to be active against all cancer cell lines and less toxic towards normal peripheral blood mononuclear cells (PBMCs). Antioxidant activity have also been investigated via free radical scavenging ability using DPPH, FRAP and ABTS assay. The tested compounds were found to exhibit moderate to good antioxidant activity which increases with increase in the concentration of steroidal dihydropyrazoles. Among all the tested steroidal dihydropyrazoles, compound 17 is found to be most active.


Subject(s)
Metal Nanoparticles , Zinc Oxide , Humans , Zinc Oxide/pharmacology , Zinc Oxide/chemistry , Antioxidants/pharmacology , Antioxidants/chemistry , Microbial Sensitivity Tests , Spectroscopy, Fourier Transform Infrared , Leukocytes, Mononuclear , Metal Nanoparticles/chemistry , Plant Extracts/chemistry
5.
ACS Omega ; 6(49): 33554-33567, 2021 Dec 14.
Article in English | MEDLINE | ID: mdl-34926904

ABSTRACT

The present study used a sol-gel auto-combustion approach to make silica (SiO2)-coated Ni-Co ferrite nanocomposites that would be used as a platform for enzyme immobilization. Using glutaraldehyde as a coupling agent, glucose oxidase (GOx) was covalently immobilized on this magnetic substrate. X-ray diffraction (XRD), scanning electron microscopy (SEM), energy-dispersive X-ray spectroscopy (EDS), high-resolution transmission electron microscopy (HRTEM), and fourier transform infrared spectroscopy (FTIR) was used to determine the structural analysis and morphology of Ni-Co ferrite/SiO2 nanocomposites. FTIR spectra confirmed the binding of GOx to Ni-Co ferrite/SiO2 nanocomposites, with a loading efficiency of around 85%. At alkaline pH and higher temperature, the immobilized GOx enzyme exhibited increased catalytic activity. After 10 times of reuses, it still had 69% catalytic activity. Overall, the immobilized GOx displayed higher operational stability than the free enzyme under severe circumstances and was easily recovered by magnetic separation. With increased doping concentration of the nanocomposites, the photocatalytic activity was assessed using a degradation process in the presence of methylene blue dye under UV light irradiation, which revealed that the surface area of the nanocomposites with increased doping concentration played a significant role in improving photocatalytic activity. The antibacterial activity of Ni-Co ferrite/SiO2 nanocomposites was assessed using the agar well diffusion method against Escherichia coli, a gram-negative bacteria (ATCC 25922). Consequently, it was revealed that doping of Ni2+ and Co2+ in Fe2O4/SiO2 nanocomposites at varied concentrations improved their antibacterial properties.

6.
BMC Nutr ; 7(1): 21, 2021 Jun 09.
Article in English | MEDLINE | ID: mdl-34103072

ABSTRACT

BACKGROUND: The adherence to a Dietary Approaches to Stop Hypertension (DASH) diet may have a bidirectional relationship with mental wellbeing. We aimed to evaluate the association between compliance with a DASH diet and neuro-psychological function in young women. METHODS: In this cross-sectional study, a total of 181 girls aged between 18 and 25 years were recruited. The dietary intakes of study participants were evaluated using a valid and reliable food frequency questionnaire (FFQ) containing 65 food items. Neuropsychological function of participants was evaluated using standard questionnaires. RESULTS: As may be expected, individuals in the highest tertile (T3) of adherence to DASH diet (highest adherence) were found to consume more folate, fruits, vegetables, low fat dairy, nuts, legume, and seed, less sweetened beverage and sodium, compared to the participants in the lowest tertile (T1, lowest adherence). There was a significant negative correlation between cognitive function and consumption of red and processed meat (r = - 0.168; p < 0.05); quality of life score with dietary sodium (r = - 0.151; p < 0.01) and depression score with dietary vegetables (r = - 0.174; p < 0.05). In multivariate multinomial logistic regression analyses adjusted for age, BMI and energy intake, adherence to a DASH-style diet was associated with a lower stress score (OR = 0.70; 95%CI: 0.34-1.47, P = 0.067; T3 vs. T1) and difficulty with sleep initiation (OR = 0.46; 95%CI: 0.21-1.00, P = 0.017; T3 vs. T1). CONCLUSION: Adherence to a DASH diet may be associated with reduced stress and difficulty with initiating sleep.

7.
Steroids ; 148: 99-113, 2019 08.
Article in English | MEDLINE | ID: mdl-31082411

ABSTRACT

A series of steroidal thiazolidinone derivatives have been synthesized through one-pot multicomponent reaction involving steroidal ketone, thiosemicarbazide/methyl-thiosemicarbazide and DMAD in presence of AlCl3 as a Lewis acid catalyst. Among all the synthesized steroidal thiazolidinone derivatives, compound 7-9 (ST 7-9) were investigated for their in vitro molecular interaction with human serum albumin. Intrinsic fluorescence spectroscopy, constant wavelength synchronous fluorescence spectroscopy, circular dichroism and UV-visible absorption techniques have been exploited to characterize the binding phenomena in phosphate buffer solution at pH 7.4. The experimental results indicated that ST 7-9 bind to HSA and the intrinsic fluorescence of HSA was quenched through static quenching mechanism. The binding parameters were calculated and the binding constants obtained were 1.44 × 105 M-1 for ST 7, 0.84 × 105 M-1 for ST 8 and 1.06 × 105 M-1 for ST 9. Circular dichroism analysis confirms that the presence of ST 7-9, altered the secondary structure of HSA due to partial unfolding of the polypeptide chain. Furthermore, hemolytic activity assay demonstrated that the synthesized steroidal thiazolidinone derivatives have good compatibility towards human red blood cells. Finally, molecular docking studies revealed that the steroidal thiazolidinones can bind in the hydrophobic cavity of HSA, by hydrophobic and hydrogen bonding interaction. These results provided valuable information about the binding mechanism of ST 7-9 with HSA and play a pivotal role in the development of steroidal heterocycle inspired compounds.


Subject(s)
Drug Design , Serum Albumin, Human/chemistry , Steroids/chemistry , Thiazolidines/chemistry , Erythrocytes/chemistry , Hemolysis , Humans , Hydrogen Bonding , Molecular Docking Simulation , Molecular Structure , Steroids/chemical synthesis , Thiazolidines/chemical synthesis
8.
Chem Sci ; 10(41): 9493-9500, 2019 Nov 07.
Article in English | MEDLINE | ID: mdl-32110305

ABSTRACT

A mild and efficient nickel-catalyzed method for the coupling of unactivated primary and secondary alkyl chlorides with the C-H bond of indoles and pyrroles is described which demonstrates a high level of chemo and regioselectivity. The reaction tolerates numerous functionalities, such as halide, alkenyl, alkynyl, ether, thioether, furanyl, pyrrolyl, indolyl and carbazolyl groups including acyclic and cyclic alkyls under the reaction conditions. Mechanistic investigation highlights that the alkylation proceeds through a single-electron transfer (SET) process with Ni(i)-species being the active catalyst. Overall, the alkylation follows a Ni(i)/Ni(iii) pathway involving the rate-influencing two-step single-electron oxidative addition of alkyl chlorides.

9.
Steroids ; 134: 22-36, 2018 06.
Article in English | MEDLINE | ID: mdl-29653115

ABSTRACT

A series of steroidal oxazole and thiazole derivatives have been synthesized employing thiosemicarbazide/semicarbazide hydrochloride and ethyl 2-chloroacetoacetate with a simple and facile one-pot multicomponent reaction pathway. The antimicrobial activity of newly synthesized compounds were evaluated against four bacterial strains namely Gram-negative (Escherichia coliand Pseudomonas aeruginosa) and Gram-positive bacteria (Staphylococcus aureus and Listeria monocytogenes) in addition to pathogenic fungi (Candida albicans and Cryptococcus neoformans). Bioactivity assay manifested that most of the compounds exhibited good antimicrobial activity. To provide additional insight into antimicrobial activity, the compounds were also tested for their antibiofilm activity against S. aureus biofilm. Moreover, molecular docking study shows binding of compounds with amino acid residues of DNA gyrase and glucosamine-6-phosphate synthase (promising antimicrobial target) through hydrogen bonding interactions. Hemolytic activity have been also investigated to ascertain the effect of compounds over RBC lysis and results indicate good prospects for biocompatibility. The expedient synthesis of steroidal heterocycles, effective antibacterial and antifungal behavior against various clinically relevant human pathogens, promising biocompatibility offer opportunities for further modification and potential applications as therapeutic agents.


Subject(s)
Biofilms/drug effects , Hemolysis/drug effects , Molecular Docking Simulation , Oxazoles/chemistry , Steroids/chemical synthesis , Steroids/pharmacology , Thiazoles/chemistry , Animals , Anti-Infective Agents/chemical synthesis , Anti-Infective Agents/chemistry , Anti-Infective Agents/metabolism , Anti-Infective Agents/pharmacology , Chemistry Techniques, Synthetic , DNA Gyrase/chemistry , DNA Gyrase/metabolism , Microbial Sensitivity Tests , Rabbits , Steroids/chemistry , Steroids/metabolism
10.
Article in English | MEDLINE | ID: mdl-28614751

ABSTRACT

Ticlopidine is an anti-platelet drug which belongs to the thienopyridine structural family and exerts its effect by functioning as an ADP receptor inhibitor. Ticlopidine inhibits the expression of TarO gene in S. aureus and may provide protection against MRSA. Groove binding agents are known to disrupt the transcription factor DNA complex and consequently inhibit gene expression. Understanding the mechanism of interaction of ticlopidine with DNA can prove useful in the development of a rational drug designing system. At present, there is no such study on the interaction of anti-platelet drugs with nucleic acids. A series of biophysical experiments were performed to ascertain the binding mode between ticlopidine and calf thymus DNA. UV-visible and fluorescence spectroscopic experiments confirmed the formation of a complex between ticlopidine and calf thymus DNA. Moreover, the values of binding constant were found to be in the range of 103M-1, which is indicative of groove binding between ticlopidine and calf thymus DNA. These results were further confirmed by studying the effect of denaturation on double stranded DNA, iodide quenching, viscometric studies, thermal melting profile as well as CD spectral analysis. The thermodynamic profile of the interaction was also determined using isothermal titration calorimetric studies. The reaction was found to be endothermic and the parameters obtained were found to be consistent with those of known groove binders. In silico molecular docking studies further corroborated well with the experimental results.


Subject(s)
DNA , Platelet Aggregation Inhibitors , Ticlopidine , Animals , Calorimetry , Cattle , DNA/chemistry , DNA/metabolism , Molecular Docking Simulation , Platelet Aggregation Inhibitors/chemistry , Platelet Aggregation Inhibitors/metabolism , Spectrometry, Fluorescence , Spectrophotometry, Ultraviolet , Ticlopidine/chemistry , Ticlopidine/metabolism , Viscosity
11.
Bioorg Chem ; 73: 83-99, 2017 08.
Article in English | MEDLINE | ID: mdl-28623723

ABSTRACT

As a part of our continuing program on the synthesis of steroidal heterocycles, it has been prepared a series of novel steroidal pyrimidine derivatives 4-6via TMSCl, steroidal ketones (1c-3c), urea and benzaldehyde. The systems presented here, are novel scaffolds and have not been described before at 6th position of steroidal-6-one (1c-3c). Structural assignment of newly synthesized compounds was performed by DFT/B3LYP calculations as well as spectral and analytical data. The interactions of compounds (4-6) with HSA were studied by fluorescence spectroscopy, DLS, CD and molecular docking, under imitated physiological conditions. The antitumor activity has been tested in vitro against three cancer cell lines MDA-MB231 (breast carcinoma), HeLa (human cervical carcinoma), HepG2 (hepatic carcinoma) and one non-cancer normal cell lines, PBMCs (peripheral blood mononuclear cell) by MTT assay. In addition, in vitro antioxidant activity and apoptosis assay of the synthesized compounds (4-6) have also been investigated.


Subject(s)
Antineoplastic Agents/pharmacology , Antioxidants/pharmacology , Molecular Docking Simulation , Pyrimidines/pharmacology , Quantum Theory , Steroids/pharmacology , Antineoplastic Agents/chemical synthesis , Antineoplastic Agents/chemistry , Antioxidants/chemical synthesis , Antioxidants/chemistry , Apoptosis/drug effects , Cell Line, Tumor , Cell Proliferation/drug effects , Dose-Response Relationship, Drug , Drug Screening Assays, Antitumor , Humans , Molecular Structure , Pyrimidines/chemical synthesis , Pyrimidines/chemistry , Steroids/chemical synthesis , Steroids/chemistry , Structure-Activity Relationship
12.
Arch Biochem Biophys ; 625-626: 1-12, 2017 07 01.
Article in English | MEDLINE | ID: mdl-28558964

ABSTRACT

Pirenzepine is an anti-ulcer agent which belongs to the anti-cholinergic group of gastrointestinal disorder drugs and functions as an M1 receptor selective antagonist. Drug-DNA interaction studies are of great significance as it helps in the development of new therapeutic drugs. It provides a deeper understanding into the mechanism through which therapeutic drugs control gene expression. Interaction of pirenzepine with calf-thymus DNA (Ct-DNA) was determined via a series of biophysical techniques. UV-visible absorption and fluorescence spectroscopy confirmed the formation of pirenzepine-Ct-DNA complex. The values of binding constant from various experiments were calculated to be in the order of 103 M-1 which is consistent with the groove binding mode. Various spectrofluorimetric experiments like competitive displacement of well known dyes with drug, iodide quenching experiments and the effect of Ct-DNA denaturation in presence of drug confirmed the binding of pirenzepine to the groove of Ct-DNA. The binding mode was further established by viscometric, circular dichroic and molecular modelling studies. Thermodynamic parameters obtained from isothermal titration calorimetric studies suggest that the interaction of pirenzepine with Ct-DNA is enthalpically driven. The value of TΔS and ΔH calculated from calorimetric studies were found to be 4.3 kcal mol-1 and -2.54 kcal mol-1 respectively, indicating that pirenzepine-Ct-DNA complex is mainly stabilized by hydrophobic interaction and hydrogen bonding. The binding energy calculated was -7.5 kcal mol-1 from modelling studies which was approximately similar to that obtained by isothermal titration calorimetric studies. Moreover, the role of electrostatic interaction in the binding of pirenzepine to Ct-DNA cannot be precluded.


Subject(s)
DNA/metabolism , Gastrointestinal Agents/metabolism , Pirenzepine/metabolism , Animals , Calorimetry , Cattle , DNA/chemistry , Molecular Docking Simulation , Nucleic Acid Conformation/drug effects , Nucleic Acid Denaturation/drug effects , Spectrometry, Fluorescence , Spectrophotometry, Ultraviolet , Thermodynamics
13.
Spectrochim Acta A Mol Biomol Spectrosc ; 179: 188-193, 2017 May 15.
Article in English | MEDLINE | ID: mdl-28242448

ABSTRACT

Aggregation of proteins is a physiological process which contributes to the pathophysiology of several maladies including diabetes mellitus, Huntington's and Alzheimer's disease. In this study we have reported that aloe emodin (AE), an anthroquinone, which is one of the active components of the Aloe vera plant, acts as an inhibitor of hemoglobin (Hb) aggregation. Hb was thermally aggregated at 60°C for four days as evident by increased thioflavin T and ANS fluorescence, shifted congo red absorbance, appearance of ß sheet structure, increase in turbidity and presence of oligomeric aggregates. Increasing concentration of AE partially reverses the aggregation of the model heme protein (hemoglobin). The maximum effect of AE was observed at 100µM followed by saturation at 125µM. The results were confirmed by UV-visible spectrometry, intrinsic fluorescence, ThT, ANS, congo red assay as well as transmission electron microscopy (TEM). These results were also supported by fourier transform infrared spectroscopy (FTIR) and circular dichroism (CD) which shows the disappearance of ß sheet structure and appearance of α helices. This study will serve as baseline for translatory research and the development of AE based therapeutics for diseases attributed to protein aggregation.


Subject(s)
Aloe/chemistry , Anthraquinones/pharmacology , Hemoglobins/chemistry , Protein Aggregates/drug effects , Temperature , Anilino Naphthalenesulfonates/chemistry , Animals , Anthraquinones/chemistry , Benzothiazoles , Cattle , Circular Dichroism , Congo Red/chemistry , Hemoglobins/ultrastructure , Nephelometry and Turbidimetry , Spectrometry, Fluorescence , Spectroscopy, Fourier Transform Infrared , Thiazoles/chemistry
14.
J Photochem Photobiol B ; 166: 104-115, 2017 Jan.
Article in English | MEDLINE | ID: mdl-27888739

ABSTRACT

In the present manuscript, a series of steroidal thiazole derivatives (4-6, 8) have been synthesized in efficient manner by one step reaction methodology employing microwave irradiation. The synthesis involves the reaction of steroidal ketones (1-3, 7) with thiosemicarbazide and phenacyl bromide. Structural assignment of the products was confirmed on the basis of IR, 1H NMR, 13C NMR, MS and analytical data. The synthesized compounds were screened for in vitro antioxidant activity by using 2,2-diphenyl-1-picrylhydrazyl (DPPH) method. In addition, the products 4-6, 8 were also tested for pBR322 DNA cleavage activity, genotoxicity, reactive oxygen species (ROS) production and RBC hemolysis. Molecular docking analysis was carried out to validate the specific binding mode of the newly synthesized compounds into the active site of DNA. Docking showed formation of more stable complexes of compounds 4 and 8 with the free binding energies -8.1 and -8kcal/mol, respectively. Hence, it could be suggested that the steroidal compounds bearing a core thiazole scaffold would be a potent biological agent.


Subject(s)
Microwaves , Thiazoles/chemistry , Comet Assay , Hemolysis/drug effects , Humans , Molecular Docking Simulation , Reactive Oxygen Species/metabolism , Spectrum Analysis , Thiazoles/pharmacology , Viscosity
15.
Eur J Med Chem ; 124: 1121-1141, 2016 Nov 29.
Article in English | MEDLINE | ID: mdl-27597727

ABSTRACT

Neurodegenerative diseases, such as Alzheimer's, Parkinson's, Creutzfeldt-Jacob, Huntington's diseases and amyotrophic lateral sclerosis, are mainly characterized by the massive deposition of misfolded protein aggregates consequent to aberrant production or overexpression of specific proteins. The development of new therapeutics for the treatment of neurodegenerative pathophysiologies currently stands at a crossroads. This presents an opportunity to transition future drug discovery efforts to target disease modification, an area in which much still remains unknown. In this review we examine recent progress in the area of neurodegenerative drug discovery, focusing on some of the most common targets.


Subject(s)
Neurodegenerative Diseases/complications , Neurodegenerative Diseases/therapy , Proteostasis Deficiencies/complications , Animals , Humans , Neurodegenerative Diseases/drug therapy , Neurodegenerative Diseases/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...